Xylem logo

Xylem Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Xylem holds $17.0B in total assets. Shareholders' equity is $11.0B against $2.6B in total debt. Cash and equivalents total $808.0M. The current ratio is 1.46 and debt-to-equity is 0.236. Based on the Q1 2026 filing.

Latest FilingQ1 2026
Report Date2026-04-28
Market Cap$25.7B
P/E Ratio26.24
ROE9.0%

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable$1.0B$958.0M$1.0B$968.0M$1.0B$969.0M
Accrued Contingent Liabilities$4.0M$4.0M$7.0M$4.0M$4.0M$4.0M
Accrued Environmental Liabilities$4.0M$4.0M$4.0M$4.0M$4.0M$4.0M
Accrued expenses$1.3B$284.0M$335.0M$335.0M$1.2B$278.0M
Accrued Manufacturing Costs$409.0M$284.0M$335.0M$335.0M$371.0M$278.0M
Other Commercial Liabilities$1.3B$1.2B$1.2B$1.2B$1.2B$1.2B
Contract liabilities$322.0M$322.0M$305.0M$298.0M$286.0M$284.0M
Accrued Income Taxes, Current$201.0M$219.0M$168.0M$155.0M$207.0M$231.0M
Accrued Liabilities, Current$1.3B$1.2B$1.2B$1.2B$1.2B$1.2B
Compensation and benefits$409.0M$284.0M$335.0M$335.0M$371.0M$278.0M
Current portion of accrued product warranty$43.0M$44.0M$45.0M$42.0M$43.0M$43.0M
Short-term borrowings and current maturities of long-term debt$38.0M$534.0M
Current portion of long-term debt$38.0M$41.0M$68.0M$49.0M$534.0M$531.0M
Deferred revenue$1.8B$1.8B$2.0B$2.0B
Finance Lease Liability, Current$27.0M$34.0M
Income taxes payable$201.0M$219.0M$168.0M$155.0M$207.0M$231.0M
Liabilities held for sale$21.0M$0.0$0.0$80.0M$72.0M$73.0M
Operating lease liabilities, current$82.0M$121.0M$128.0M$127.0M$121.0M$123.0M
Other current liabilities$758.0M$748.0M$798.0M$821.0M$822.0M$899.0M
Restructuring Reserve$25.0M$22.0M$29.0M$35.0M$145.0M
Standard Product Warranty Accrual$57.0M$60.0M$61.0M$51.0M$53.0M$53.0M
Supplier Finance Program Obligations$250.0M$264.0M$278.0M$255.0M$244.0M$234.0M
Total current liabilities$2.3B$2.2B$2.3B$2.3B$2.9B$2.8B

Equity

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
AOCI - Cash Flow Hedge Reclassification (Next 12 Months)$1.0M$17.0M$13.0M$3.0M
Accrued restructuring liabilities$34.0M$26.0M
Allowance for doubtful accounts$59.0M$53.0M$61.0M$66.0M$68.0M$53.0M
Common stock, par value (in dollars per share)$0.0$0.0$0.0$0.0$0.0$0.0
Common stock, shares authorized (in shares)$750.0M$750.0M$750.0M$750.0M$750.0M$750.0M
Common stock, shares issued (in shares)$259.2M$259.7M$259.7M$259.8M$259.9M$260.3M
Contract with Customer, Liability$322.0M$313.0M$305.0M$298.0M$286.0M$284.0M
Customer Related Liabilities Current$384.0M$390.0M$385.0M$382.0M$370.0M$372.0M
Short-term debt and current portion of long-term debt$38.0M$41.0M$68.0M$49.0M$534.0M$531.0M
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net$14.0M$13.0M$13.0M$12.0M
Deferred income taxes$497.0M$486.0M$427.0M$492.0M$405.0M$437.0M
Current maturities of long-term debt$27.0M$34.0M
Finite-Lived Intangible Assets, Accumulated Amortization$1.3B$1.4B$1.5B$1.5B$1.5B$1.5B
Guarantor obligations, current carrying value$758.0M$748.0M$798.0M$821.0M$822.0M$899.0M
Indefinite- lived intangible impairment$3.6B$3.7B$3.8B$3.8B$3.8B$3.7B
2028$521.0M$17.0M$12.0M$508.0M
2029$519.0M$512.0M$507.0M$1.0M
2030$15.0M$18.0M$3.0M$0.0
2027$41.0M$520.0M$515.0M$11.0M
Remainder of 2026$35.0M$28.0M$530.0M
Thereafter$907.0M$910.0M$900.0M
Loss Contingency Accrual$4.0M$4.0M$7.0M$4.0M$4.0M$4.0M
Noncontrolling interests in subsidiaries$5.0M$6.0M$7.0M$12.0M$11.0M$8.0M
Net investment hedge gain (loss) to be reclassified during next 12 months$0.0$0.0
Other accrued liabilities$125.0M$109.0M$125.0M$131.0M$91.0M$109.0M
Redeemable noncontrolling interests in subsidiaries$235.0M$232.0M$228.0M$226.0M$258.0M$249.0M
Restructuring Reserve$25.0M$22.0M$29.0M$35.0M$34.0M$27.0M
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied$1.8B$1.8B$2.0B$2.0B
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price$92.3$93.3$94.7$100.8
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number$905.0K$863.0K$815.0K$896.0K
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number$1.2M$1.3M$1.3M$1.2M$1.1M$1.4M
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number$1.3M$1.2M$1.2M$1.3M
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value$38.0M$43.0M$58.0M$29.0M
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price$84.8$94.2$94.9$96.0$95.8$102.4
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value$40.0M$38.0M$43.0M$58.0M$46.0M$29.0M
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price$78.3$79.3$80.0$87.1
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value$38.0M$42.0M$51.0M$29.0M
Standard Product Warranty Accrual$57.0M$60.0M$61.0M$51.0M$53.0M$53.0M
Supplier finance program, obligation$250.0M$264.0M$278.0M$255.0M$244.0M$234.0M
Treasury stock, shares (in shares)$16.2M$16.3M$16.3M$16.3M$16.3M$21.2M
Unamortized Debt Issuance Expense$15.0M$14.0M$13.0M$13.0M$12.0M$12.0M
Remainder of Fiscal Year 2024$35.0M$28.0M$530.0M